HealthcareNYSElarge
Institutional-grade research for retail investors
SEC EDGAR: CIK 845982SNN stock profile & AI dashboard →
InternationalScored off the official board: an annual-only filer, so this data lags a domestic quarterly filer.

13F Pro Quality Score

45.5/100

Rank #1,866 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

SNN Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for SMITH & NEPHEW PLC (SNN), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores SNN at 45.5/100 on a 32-signal composite quality model, placing it at rank #1,866 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (FY 2017), SMITH & NEPHEW PLC reports quarterly revenue of $4.8B, net income of $767.0M. Top institutional holders of SNN by reported 13-F value include River Road Asset Management, GOLDMAN SACHS GROUP, BRANDES INVESTMENT PARTNERS, based on the most recent SEC filings. SNN trades on the NYSE exchange and files with the SEC under CIK 845982. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SNN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for SMITH & NEPHEW PLC directly from SEC EDGAR. SMITH & NEPHEW PLC's 13F Pro composite quality score has ranged between 39 and 46 since 2026, currently 45.5 — an improving long-term trajectory across 47 quarterly and live scoring snapshots.

Revenue

FY 2017

$4.8B

Net Income

FY 2017

$767.0M

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Total Assets

+1.0% YoY
$10.46BFY 2025
FY22 $9.97BFY23 $9.99BFY24 $10.35BFY25 $10.46B

Get alerted when SNN's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for SMITH & NEPHEW PLC including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of SNN

Companies Similar to SNN

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

PHG

KONINKLIJKE PHILIPS NV

40
AI score
Very similar · 21 shared holders
TAK

TAKEDA PHARMACEUTICAL CO LTD

37
AI score
Similar quality profile · 22 shared holders
AZN

ASTRAZENECA PLC

47
AI score
Similar quality profile · 4 shared holders
NVO

NOVO NORDISK A S

52
AI score
Similar quality profile · 4 shared holders
RDY

DR REDDYS LABORATORIES LTD

46
AI score
Similar quality profile · 7 shared holders
NGG

NATIONAL GRID PLC

44
AI score
Similar quality profile · 21 shared holders
GSK

GSK plc

44
AI score
Similar quality profile · 9 shared holders
HLN

Haleon plc

44
AI score
Similar quality profile · 20 shared holders

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

Put SNN on your watchlist

Track score changes the day SMITH & NEPHEW PLC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is SNN a good stock to buy?

13F Pro's AI-powered analysis of SMITH & NEPHEW PLC (SNN) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for SNN are available on the SNN stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. SNN is classified as a large company.

Which hedge funds own SNN?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling SNN. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of SMITH & NEPHEW PLC's investment landscape.